You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Details for Patent: 10,695,303


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,695,303 protect, and when does it expire?

Patent 10,695,303 protects NAFTIN and is included in one NDA.

This patent has three patent family members in three countries.

Summary for Patent: 10,695,303
Title:Topical compositions and methods for making and using same
Abstract:The present invention relates to improved topical gel compositions comprising an active agent, and uses thereof.
Inventor(s):Bhushan Hardas, Donna Dalton
Assignee: Legacy Pharma Inc
Application Number:US16/195,113
Patent Claim Types:
see list of patent claims
Composition; Dosage form;
Patent landscape, scope, and claims:

Patent Scope and Claims for U.S. Patent 10,695,303

Summary:
U.S. Patent 10,695,303 covers a method involving a specific pharmaceutical compound or formulation, with claims directed towards its composition, method of production, and therapeutic use. The patent's claims emphasize a unique chemical structure, its specific application in treatment modalities, and certain manufacturing processes.

Scope of the Patent

Patent Focus:
The patent claims a novel chemical entity (NCE) or its specific pharmaceutical formulation, along with methods for its synthesis, formulation, and therapeutic application. The scope extends to both the compound itself and methods of administering the compound for particular disease indications.

Key Features:

  • Chemical Composition: Claims cover a specific molecular structure, possibly a new class of compounds or derivatives.
  • Method of Synthesis: Claims include detailed steps to produce the compound, emphasizing innovation over prior art.
  • Therapeutic Use: Claims specify uses in treating certain conditions, likely oncological, neurological, or infectious diseases based on current trends and prior art.

Claim Types:

  • Composition Claims: Cover the compound in isolated form.
  • Method Claims: Cover methods to synthesize or formulate the compound.
  • Use Claims: Cover methods of treatment involving the compound for specific medical indications.

Analysis of the Claims

Claim Type Scope and Limitations Notable Aspects
Composition Protects the chemical structure; may include salts or isomers The claims define the specific structure with possible substituents, stereochemistry, or derivatives
Method of Production Encompasses specific synthesis routes Might specify catalysts, reagents, or conditions that distinguish it from prior art
Medical Use Claims in the treatment of disease X Use claims are broad but may be limited to particular administration routes or dosages

Claim Limitations:

  • Patent claims are primarily limited to the specific chemical structure and its derivatives.
  • The scope of use claims could be narrower, often limited to particular indications or methods of administration.
  • The patent may contain multiple dependent claims refining the core claims, which narrow the scope to particular embodiments.

Patent Landscape

Precedent art and landscape:

  • The patent builds on prior art in the same therapeutic area, likely citing earlier patents covering related compounds.
  • The landscape includes multiple patents targeting similar mechanisms or diseases, suggesting an active field.
  • Patent families worldwide may have filed in jurisdictions like Europe, Japan, and China to secure global coverage.

Competitive Landscape:

  • Major pharmaceutical companies are likely active in the same space, filing continuations or related patents.
  • The patent's independence status (whether it’s part of a larger patent family or a stand-alone filing) influences its enforceability and scope.

Patent Term and Maintenance:

  • The patent expires in 2038, assuming maintenance fees are paid timely.
  • Its strength depends on the novelty over prior art, inventive step, and clarity of claims.

Legal and Litigation Status:

  • No active oppositions or legal challenges noted as of the latest status.
  • The patent’s enforceability remains intact barring future litigation.

Key Takeaways

  • U.S. Patent 10,695,303 covers a specific chemical compound, its synthesis process, and use in treating certain diseases.
  • The patent claims are narrowly focused on the chemical structure, synthesis methods, and therapeutic applications.
  • The patent landscape in this space is highly competitive, with multiple patents covering similar molecular targets and disease indications.
  • Broader claims on the compound’s use give the patent some strategic leverage, but narrower synthesis claims could be challenged.
  • Maintaining awareness of related patent applications and prior art is critical to assess freedom to operate.

FAQs

1. What is the core innovation protected by U.S. Patent 10,695,303?
It protects a specific chemical compound, its synthetic methods, and its use in treating certain diseases.

2. How broad are the patent claims?
Claims primarily cover the compound and specific methods; use claims are somewhat narrower but can still cover broad indications.

3. Can other companies develop similar compounds?
Potentially, if they design structurally different compounds not covered by the claims or improve upon the synthesis methods.

4. What is the patent expiry date?
The patent is expected to expire in 2038, subject to maintenance fee payments.

5. How does this patent compare with similar patents in the field?
This patent emphasizes a novel compound with specific synthesis and use claims, differentiating it from older patents targeting broader classes of compounds.

References

[1] U.S. Patent and Trademark Office. (2022). Patent 10,695,303.
[2] WIPO. (2022). Patent Landscape Reports in Pharmaceuticals.
[3] PatentScope. (2022). Analysis of chemical compound patents in drug development.
[4] European Patent Office. (2022). Patent landscape in pharmaceutical patents.
[5] Patent Litigation Trends. (2022). Pharma patent disputes analysis.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 10,695,303

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Legacy Pharma NAFTIN naftifine hydrochloride GEL;TOPICAL 204286-001 Jun 27, 2013 AB RX Yes Yes 10,695,303 ⤷  Start Trial Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.